Phase 2 Study of SAR439859 Versus Physician's Choice in Premenopausal and Postmenopausal Locally Advanced or Metastatic ER-positive Breast Cancer

Condition:   Breast Cancer Metastatic Interventions:   Drug: SAR439859;   Drug: Endocrine monotherapy as per physician choice Sponsor:   Sanofi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials